$91.4 Million is the total value of Asymmetry Capital Management, L.P.'s 29 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| APLS | Exit | APELLIS PHARMACEUTICALS | $0 | – | -21,380 | -100.0% | -1.17% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -6,950 | -100.0% | -1.61% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -256,205 | -100.0% | -1.94% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -49,431 | -100.0% | -2.12% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -15,004 | -100.0% | -2.20% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -20,791 | -100.0% | -2.42% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC | $0 | – | -22,872 | -100.0% | -2.44% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -81,127 | -100.0% | -2.58% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -62,507 | -100.0% | -2.71% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -18,921 | -100.0% | -3.00% | – |
| REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -4,584 | -100.0% | -3.08% | – |
| MYL | Exit | MYLAN NV | $0 | – | -132,855 | -100.0% | -4.79% | – |
| INSM | Exit | INSMED INC | $0 | – | -113,875 | -100.0% | -4.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CENTENE CORP | 21 | Q4 2021 | 10.7% |
| UNITEDHEALTH GROUP INC | 21 | Q4 2021 | 7.2% |
| AMICUS THERAPEUTICS INC | 20 | Q4 2021 | 8.0% |
| PTC THERAPEUTICS INC | 19 | Q3 2021 | 13.8% |
| AERIE PHARMACEUTICALS INC | 16 | Q4 2019 | 9.9% |
| JAZZ PHARMACEUTICALS PLC | 15 | Q2 2021 | 10.2% |
| BIO-RAD LABRATORIES | 13 | Q2 2021 | 6.3% |
| NEVRO CORP | 12 | Q3 2018 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 12 | Q4 2018 | 6.5% |
| NUCANA PLC-ADR | 12 | Q4 2020 | 2.6% |
View Asymmetry Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-01-19 |
| 13F-HR | 2021-11-04 |
| 13F-HR | 2021-07-28 |
| 13F-HR | 2021-05-11 |
| 13F-HR | 2021-02-11 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-06 |
| 13F-HR | 2020-05-13 |
| 13F-HR | 2020-02-12 |
| 13F-HR | 2019-11-12 |
View Asymmetry Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.